NCT03658876已完成4 期
Predictors of Response to Iron and Erythropoietin Stimulating Agents
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 197
- 主要终点
- Hemoglobin Incrementation
研究概览
简要总结
The purpose of the study is to identify predictors of treatment response. This involves collected baseline clinical parameters and bloods for biochemical parameters prior to administering the study treatment. A positive outcome following treatment was defined as an uptitration of haemoglobin by greater than 5g/l within 2 months. The study evaluated the participants response to treatment against the clinical and biochemical information collected prior to treatment being received.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All prevalent haemodialysis patients, established for greater than 3 months
排除标准
- •Inability to consent Bone marrow disorder Transfusion dependence Active bleeding Active infection Active malignancy Frail with either frequent hospital admissions or unable to follow trial protocol due to differing target haemoglobin
研究组 & 干预措施
EPO group
Active Comparator
干预措施: Epoetin Beta (Drug)
Iron group
Active Comparator
干预措施: Iron Sucrose Solution for Injection (Drug)
结局指标
主要结局
Hemoglobin Incrementation
时间窗: Within 2 months
Incrementation of haemoglobin of 5g/l following treatment
次要结局
未报告次要终点
研究者
相似试验
终止
不适用
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving ChemotherapyAnemia - Cancer RelatedNCT01736215Janssen-Cilag Ltd.,Thailand33
招募中
不适用
Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL StudyBiliary Tract CancerNCT04935853GERCOR - Multidisciplinary Oncology Cooperative Group1,350
招募中
不适用
Prognostic and Predictive Markers of Treatment Response in Patients With PAC.Pancreatic AdenocarcinomaNCT05776342GERCOR - Multidisciplinary Oncology Cooperative Group4,050
已完成
不适用
A Study on predictors of treatment response concerning of the efficacy of tolvaptan on refractory ascites.iver cirrhosis with refractory ascites.JPRN-UMIN000026426The third department of internal medicine, Nara Medical University30
已完成
不适用
Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric CancerEsophageal NeoplasmsStomach NeoplasmsNCT02305043University of Leipzig549